Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC Filings

SEC Filings

Search
Filing date Form Description View
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-18-009542.pdf
0001558370-18-009542.rtf
0001558370-18-009542.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-013049.pdf
0001179110-18-013049.rtf
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-18-009374.pdf
0001558370-18-009374.rtf
0001558370-18-009374.xls
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-012637.pdf
0001179110-18-012637.rtf
4

Statement of changes in beneficial ownership of securities

 View HTML
0001179110-18-012562.pdf
0001179110-18-012562.rtf
3

Initial filing by director officer or owner of more than ten percent.

 View HTML
0001179110-18-012561.pdf
0001179110-18-012561.rtf
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-18-008009.pdf
0001558370-18-008009.rtf
0001558370-18-008009.xls
10-Q

Quarterly report which provides a continuing view of a company's financial position

 View HTML
0001558370-18-008072.pdf
0001558370-18-008072.rtf
0001558370-18-008072.xls
EX-101.INS - EX-101.INS
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-18-007980.pdf
0001558370-18-007980.rtf
0001558370-18-007980.xls
8-K

Report of unscheduled material events or corporate event

 View HTML
0001558370-18-007655.pdf
0001558370-18-007655.rtf
0001558370-18-007655.xls